Skip to main content
Premium Trial:

Request an Annual Quote

RareCyte: David Kabakoff, Andy Schwab

In conjunction with RareCyte's recent financing round, David Kabakoff and Andy Schwab have joined the company's board of directors. Kabakoff is a partner at HealthQuest Capital and Schwab is a managing partner at 5AM Ventures. Both companies are RareCyte investors.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.